ALMS
Price
$3.88
Change
+$0.02 (+0.52%)
Updated
Jul 25 closing price
Capitalization
400.37M
23 days until earnings call
SLNO
Price
$86.47
Change
-$1.56 (-1.77%)
Updated
Jul 25 closing price
Capitalization
4.56B
10 days until earnings call
Interact to see
Advertisement

ALMS vs SLNO

Header iconALMS vs SLNO Comparison
Open Charts ALMS vs SLNOBanner chart's image
Alumis
Price$3.88
Change+$0.02 (+0.52%)
Volume$660.81K
Capitalization400.37M
Soleno Therapeutics
Price$86.47
Change-$1.56 (-1.77%)
Volume$790.65K
Capitalization4.56B
ALMS vs SLNO Comparison Chart in %
Loading...
ALMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALMS vs. SLNO commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALMS is a StrongBuy and SLNO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (ALMS: $3.88 vs. SLNO: $86.47)
Brand notoriety: ALMS and SLNO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALMS: 70% vs. SLNO: 70%
Market capitalization -- ALMS: $400.37M vs. SLNO: $4.56B
ALMS [@Biotechnology] is valued at $400.37M. SLNO’s [@Biotechnology] market capitalization is $4.56B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALMS’s FA Score shows that 1 FA rating(s) are green whileSLNO’s FA Score has 0 green FA rating(s).

  • ALMS’s FA Score: 1 green, 4 red.
  • SLNO’s FA Score: 0 green, 5 red.
According to our system of comparison, SLNO is a better buy in the long-term than ALMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALMS’s TA Score shows that 3 TA indicator(s) are bullish while SLNO’s TA Score has 3 bullish TA indicator(s).

  • ALMS’s TA Score: 3 bullish, 3 bearish.
  • SLNO’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ALMS is a better buy in the short-term than SLNO.

Price Growth

ALMS (@Biotechnology) experienced а +16.52% price change this week, while SLNO (@Biotechnology) price change was -0.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

ALMS is expected to report earnings on Aug 19, 2025.

SLNO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNO($4.56B) has a higher market cap than ALMS($400M). SLNO YTD gains are higher at: 92.369 vs. ALMS (-50.636). SLNO has higher annual earnings (EBITDA): -194.63M vs. ALMS (-354.69M). SLNO has more cash in the bank: 290M vs. ALMS (209M). ALMS has less debt than SLNO: ALMS (31.9M) vs SLNO (52.8M). ALMS has higher revenues than SLNO: ALMS (17.4M) vs SLNO (0).
ALMSSLNOALMS / SLNO
Capitalization400M4.56B9%
EBITDA-354.69M-194.63M182%
Gain YTD-50.63692.369-55%
P/E RatioN/AN/A-
Revenue17.4M0-
Total Cash209M290M72%
Total Debt31.9M52.8M60%
FUNDAMENTALS RATINGS
SLNO: Fundamental Ratings
SLNO
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
36
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALMSSLNO
RSI
ODDS (%)
Bullish Trend 3 days ago
63%
Bearish Trend 3 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
58%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
68%
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
57%
Bullish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 4 days ago
87%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ALMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FXLV0.080.01
+7.21%
F45 Training Holdings Inc.
TKAMY13.030.29
+2.28%
ThyssenKrupp AG
ALPKF0.57N/A
N/A
Alpek SAB DE CV
EMHLF0.14N/A
N/A
European Metals Holdings Ltd.
IDEXF50.37-1.50
-2.90%
Industria de Diseno Textil Inditex SA

ALMS and

Correlation & Price change

A.I.dvisor tells us that ALMS and ADAP have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALMS and ADAP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALMS
1D Price
Change %
ALMS100%
+0.52%
ADAP - ALMS
30%
Poorly correlated
+19.62%
SLNO - ALMS
28%
Poorly correlated
-1.77%
CCCC - ALMS
27%
Poorly correlated
-1.31%
ATXS - ALMS
27%
Poorly correlated
+1.37%
KRRO - ALMS
26%
Poorly correlated
+0.69%
More

SLNO and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLNO has been loosely correlated with SYRE. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLNO jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNO
1D Price
Change %
SLNO100%
-1.77%
SYRE - SLNO
43%
Loosely correlated
+1.08%
NKTX - SLNO
41%
Loosely correlated
+0.93%
CRNX - SLNO
39%
Loosely correlated
N/A
RVMD - SLNO
39%
Loosely correlated
N/A
IMVT - SLNO
39%
Loosely correlated
-7.48%
More